Innovation
1 patent family — focus: Chemistry & metallurgy, Physics & computing; filing pace active. Cited 2 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2026 | 1 |
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Developer of methylation based diagnostic tests for esophageal cancer risk
1 patent family — focus: Chemistry & metallurgy, Physics & computing; filing pace active. Cited 2 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2026 | 1 |
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |